Skip to content
OpenSampling

The Library

Papers on microsampling and monitoring, each with a finding paraphrased to our standard and labelled in one vocabulary. With a free account, every entry links to a legitimate copy; nothing is copied from an abstract.

Papers 1–5 of 51 labelled “Multi-omics”, newest first.

  1. 2026

    Development and Validation of a Streamlined Workflow for Proteomic Analysis of Proteins and Post-translational Modifications from Dried Blood

    A streamlined workflow quantified up to 10,000 protein groups and post-translational modifications from 20 microlitres of dried blood collected by volumetric absorptive microsampling, with mass spectrometry acquisition under two hours.

    Foster et al., Journal of proteome research (paywalled)

  2. 2026

    Artificial Intelligence in Neuromuscular Diseases: Opportunities for a Data-Scarce Field

    Wearable-derived digital biomarkers have been accepted by regulatory agencies as endpoints in clinical trials for Duchenne muscular dystrophy, showing their potential to support decentralised diagnostics through patient-centric monitoring.

    Ma et al., Neurology and therapy (paywalled)

  3. 2026

    Microsampling of proteins from biological matrices: sampling methods and devices, typical workflows, clinical examples, novel applications and innovations

    This review finds that dried microsampling has matured from simple blood spots into diverse devices capable of therapeutic drug monitoring, multiplex biomarker profiling, and multi-omics, with integrated smart sampling and dried immunoassays now ready for field use.

    Halvorsen et al., Analytical methods (paywalled)

  4. 2026

    Natural daylight during office hours improves glucose control and whole-body substrate metabolism

    In adults with type 2 diabetes, exposure to natural daylight during office hours increased time in the normal glucose range

    Harmsen et al., Cell metabolism (paywalled)

  5. 2026

    Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study

    The High-Definition Oncology feasibility study in 30 women with metastatic cancer demonstrated high adherence to biospecimen collection (97.4% plasma, 80.7% stool) and wearable monitoring (70–95% of days captured for activity, heart rate, sleep, and oxygen saturation).

    Garma et al., JCO precision oncology (paywalled)

Browse the whole Library with a free account

A free account opens every page of every view, search, and every finding in full with its source.

Create a free accountSign in

Read from the corpus on .